iSpecimen Inc (ISPC)
0.3916
0.00 (0.00%)
USD |
NASDAQ |
Jun 20, 16:00
0.3999
+0.01
(+2.12%)
After-Hours: 20:00
iSpecimen Cash from Financing (Quarterly): -0.1189M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.1189M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0032M |
| March 31, 2023 | 0.0677M |
| December 31, 2022 | -3.500M |
| September 30, 2022 | -0.005M |
| June 30, 2022 | 0.0081M |
| March 31, 2022 | 0.0753M |
| Date | Value |
|---|---|
| December 31, 2021 | 19.57M |
| September 30, 2021 | 2.977M |
| June 30, 2021 | 16.20M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.25M |
| June 30, 2020 | 0.783M |
| March 31, 2020 | 1.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.500M
Minimum
Dec 2022
19.57M
Maximum
Dec 2021
2.195M
Average
0.0081M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| RadNet Inc | 228.30M |
| DermTech Inc | 0.122M |
| 23andMe Holding Co | 2.00M |
| Sera Prognostics Inc | 1.054M |
| Progyny Inc | -27.41M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.072M |
| Cash from Investing (Quarterly) | 1.937M |
| Free Cash Flow | -8.536M |
| Free Cash Flow Per Share (Quarterly) | -0.2581 |
| Free Cash Flow to Equity (Quarterly) | -2.357M |
| Free Cash Flow Yield | -240.1% |